Federal Act on Medicinal Products and Medical Devices
GPTKB entity
Properties (44)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
legislation
|
| gptkbp:addresses |
drug pricing
access to medicines |
| gptkbp:aimsTo |
ensure safety of medical devices
ensure safety of medicinal products |
| gptkbp:amends |
various amendments
|
| gptkbp:associated_with |
WHO guidelines
|
| gptkbp:compatibleWith |
European_Union_regulations
|
| gptkbp:consequences |
non-compliance
|
| gptkbp:defines |
medical device
medicinal product |
| gptkbp:effectiveDate |
2000
|
| gptkbp:enforces |
gptkb:Swiss_Federal_Office_of_Public_Health
|
| gptkbp:established |
gptkb:Swiss_Federal_Assembly
|
| https://www.w3.org/2000/01/rdf-schema#label |
Federal Act on Medicinal Products and Medical Devices
|
| gptkbp:influenced |
international standards
|
| gptkbp:is_a_subject_of |
public consultation
judicial review |
| gptkbp:is_designed_to |
protect public health
|
| gptkbp:is_governed_by |
Swiss_Agency_for_Therapeutic_Products
|
| gptkbp:is_part_of |
regulatory framework
healthcare_policy Swiss_public_health_law |
| gptkbp:is_supported_by |
stakeholder engagement
|
| gptkbp:judgingCriteria |
government agencies
|
| gptkbp:mandates |
adverse events
pharmacovigilance post-market surveillance market authorization |
| gptkbp:promotes |
research and development in pharmaceuticals
|
| gptkbp:provides |
clinical trials
|
| gptkbp:provides_access_to |
innovative therapies
|
| gptkbp:regulates |
medical devices
medicinal products |
| gptkbp:requires |
medical devices
medicinal products |
| gptkbp:suitableFor |
clinical laboratories
manufacturers distributors wholesalers importers healthcare_professionals |
| gptkbp:supports |
patient safety
|
| gptkbp:was_a_response_to |
public health needs
|